Celeste Mellet is recorded as CFO at Humana Inc (HUM). Earlier roles on record: CFO at Evercore Inc. (EVR) until October 26, 2022. Humana Inc reported in an 8-K filed December 3, 2024 that Celeste Mellet was appointed Chief Financial Officer, effective January 11, 2025. Evercore Inc. reported in an 8-K filed October 26, 2022 that Celeste Mellet resigned as Senior Managing Director and Chief Financial Officer. Celeste Mellet has spoken on 10 earnings calls across 2 companies, most recently for Humana Inc on July 29, 2026. Those appearances were for Humana Inc (HUM) and Evercore Inc. (EVR). Humana Inc is classified in the Healthcare Plans industry within the Healthcare sector. Other companies whose calls Celeste Mellet spoke on are classified in the Financial Services sector. Other leadership on record at Humana Inc includes Bruce D. Broussard (CEO), James A. Rechtin (CEO, COO and Board Member), Kurt J. Hilzinger (Chairman) and 7 others.
“the Company also announced the appointment of Celeste Mellet, age 48, to serve as the Company's Chief Financial Officer, effective as of January 11, 2025.”
Humana Inc Form 8-K, filed December 3, 2024
· Read the filing
“On October 20, 2022, Celeste Mellet, Senior Managing Director and Chief Financial Officer of Evercore Inc. (the "Company"), notified the Company of her intention to resign from the Company in order to pursue a position in an entirely different area of finance with a large, international alternative asset fund manager.”
Evercore Inc. Form 8-K, filed October 26, 2022
· Read the filing
Celeste Mellet on recent calls
“I will start with our comments on our 26th performance and 27 MA bid approach, before touching on continued progress on balance sheet efficiency and capital optimization.”
“There are a couple of items I will briefly address before we begin Q&A. First, we are pleased that available information to date suggests that our Medicare Advantage members, both new and existing, are performing in line to better than our guidance even after adjusting for a more subdued flu season and the winter…”
“Our third quarter results reflect solid execution and underlying fundamentals, including membership and patient growth, revenue and medical cost trends that continue to develop consistent with our expectations.”
“I would reinforce that while it remains early, we've had a solid start to the year. The underlying fundamentals of the business, including membership and patient growth, revenue and medical cost trends are developing as expected.”
